Masayasu Matsumoto Selected Research

Masayasu Matsumoto Research Topics

Disease

56	Stroke (Strokes) 11/2021 - 09/2002
36	Ischemic Stroke 11/2021 - 09/2005
15	Hypertension (High Blood Pressure) 01/2021 - 02/2003
14	Atrial Fibrillation 02/2017 - 02/2006
12	Ischemia 11/2006 - 01/2002
11	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2002
9	Hemorrhage 11/2021 - 02/2006
9	Transient Ischemic Attack 05/2019 - 06/2003
8	Atherosclerosis 02/2021 - 02/2002
7	Infarction (Infarctions) 06/2020 - 04/2004
7	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 06/2010
7	Carotid Artery Diseases 06/2018 - 06/2002
7	Brain Ischemia (Cerebral Ischemia) 07/2017 - 04/2002
7	Cerebral Infarction 01/2014 - 06/2002
6	Myocardial Infarction 10/2021 - 12/2005
6	Embolic Stroke 01/2019 - 04/2016
6	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014 - 10/2003
5	Lacunar Stroke 05/2020 - 06/2002
5	Inflammation (Inflammations) 05/2018 - 05/2003
5	Diabetes Mellitus 04/2018 - 01/2012
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 12/2005
5	Embolism (Embolus) 11/2013 - 09/2005
4	Hyperlipidemias (Hyperlipidemia) 04/2018 - 07/2012
4	Hypoxia (Hypoxemia) 03/2012 - 11/2006
3	Pathologic Constriction (Stenosis) 10/2021 - 05/2003
3	Dyskinesias (Dyskinesia) 05/2018 - 09/2008
3	Neoplasms (Cancer) 03/2018 - 01/2011
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2016 - 06/2010
3	Dyslipidemias (Dyslipidemia) 01/2016 - 01/2014
3	Cognitive Dysfunction 01/2013 - 01/2004
3	Atrophy 01/2013 - 06/2003
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2006 - 02/2004
2	Frontotemporal Dementia (Semantic Dementia) 10/2018 - 06/2010
2	Myotonic Dystrophy (Dystrophia Myotonica) 10/2018 - 10/2012
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2018 - 02/2006
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 09/2016
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 10/2013
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 10/2016 - 04/2004
2	Dementia (Dementias) 06/2014 - 01/2004
2	Progressive Multifocal Leukoencephalopathy 01/2013 - 01/2012
2	Thrombosis (Thrombus) 05/2012 - 09/2005
2	Multiple Sclerosis 06/2008 - 08/2003
2	Gliosis 02/2006 - 06/2003

Drug/Important Bio-Agent (IBA)

17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2020 - 12/2005
14	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2002
14	Warfarin (Coumadin)FDA LinkGeneric 02/2017 - 09/2005
11	Pravastatin (Pravachol)FDA LinkGeneric 06/2020 - 02/2014
9	Clopidogrel (Plavix)FDA Link 11/2021 - 01/2008
8	RivaroxabanIBA 12/2016 - 01/2012
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 12/2005
7	AnticoagulantsIBA 08/2016 - 09/2005
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 09/2005
6	C-Reactive ProteinIBA 05/2019 - 03/2004
6	UbiquitinIBA 10/2012 - 11/2003
5	Cilostazol (Pletal)FDA LinkGeneric 11/2021 - 12/2005
5	LDL CholesterolIBA 05/2020 - 04/2016
5	alpha-SynucleinIBA 08/2010 - 06/2002
4	Prasugrel Hydrochloride FDA Link 02/2021 - 04/2018
4	LDL Lipoproteins (beta Lipoproteins)IBA 05/2020 - 01/2017
4	Neuroprotective AgentsIBA 01/2019 - 04/2002
4	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 01/2004
4	Heparin (Liquaemin)FDA LinkGeneric 09/2016 - 09/2005
4	Indicators and Reagents (Reagents)IBA 01/2016 - 02/2003
4	Ticlopidine (Ticlid)FDA LinkGeneric 07/2014 - 09/2005
4	Apolipoproteins E (ApoE)IBA 07/2006 - 02/2002
4	ApolipoproteinsIBA 07/2006 - 02/2002
3	salicylhydroxamic acid (SHAM)IBA 05/2018 - 03/2002
3	fibrin fragment D (D-dimer)IBA 03/2018 - 01/2011
3	danaparoid (Orgaran)FDA Link 03/2018 - 01/2011
3	LipidsIBA 01/2018 - 06/2014
3	tau Proteins (tau Protein)IBA 07/2017 - 02/2006
3	Hemoglobins (Hemoglobin)IBA 06/2017 - 07/2012
3	Messenger RNA (mRNA)IBA 04/2016 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2009
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2015 - 01/2014
3	Vitamin K FDA Link 01/2015 - 04/2012
3	AntibodiesIBA 06/2013 - 12/2006
3	Glutamic Acid (Glutamate)FDA Link 05/2003 - 04/2002
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2021 - 10/2021
2	EnzymesIBA 12/2018 - 10/2003
2	cilnidipineIBA 06/2018 - 01/2017
2	AntigensIBA 01/2017 - 08/2003
2	Therapeutic UsesIBA 01/2017 - 11/2011
2	CholesterolIBA 02/2014 - 07/2007
2	Angiotensin Receptor AntagonistsIBA 12/2013 - 11/2011
2	Mefloquine (Lariam)FDA LinkGeneric 01/2013 - 01/2012
2	Oxygen (Dioxygen)IBA 05/2012 - 09/2002
2	Factor Xa InhibitorsIBA 04/2012 - 01/2012
2	Small Interfering RNA (siRNA)IBA 03/2012 - 11/2006
2	Angiotensin IIIBA 11/2011 - 04/2011
2	Levodopa (L Dopa)FDA LinkGeneric 09/2011 - 09/2008
2	Mixed Function Oxygenases (Monooxygenases)IBA 03/2008 - 02/2007
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2007 - 11/2003
2	Bromodeoxyuridine (BrdU)IBA 11/2006 - 03/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004 - 05/2003
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2003 - 02/2002
2	AntioxidantsIBA 11/2002 - 04/2002

Therapy/Procedure

26	Therapeutics 11/2021 - 09/2005
7	Secondary Prevention 01/2019 - 12/2005
2	Aftercare (After-Treatment) 10/2016 - 01/2013